Sehgal VN, Verma P, Srivastava G et al (2011-12). “Melasma: treatment strategy”. Journal of cosmetic and laser therapy13 (6): 265–279. doi:10.3109/14764172.2011.630088. PMID21981383.
Qianyun Chai, Yutong Fei, Huijuan Cao, Congcong Wang, Jinzhou Tian, Jianping Liu (2015-8). “Acupuncture for melasma in women: a systematic review of randomised controlled trials”. Acupuncture in medicine : journal of the British Medical Acupuncture Society33 (4): 254–261. doi:10.1136/acupmed-2014-010633. PMID25900923.
Ennes, SBP; Paschoalick, RC; Alchorne, M Mota De Avelar (2009). “A double-blind, comparative, placebo-controlled study of the efficacy and tolerability of 4% hydroquinone as a depigmenting agent in melasma”. Journal of Dermatological Treatment11 (3): 173–179. doi:10.1080/09546630050517333.
Huh CH, Seo KI, Park JY et al (2003). “A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma”. Dermatology (Basel, Switzerland)206 (4): 316–320. doi:10.1159/000069943. PMID12771472.
Hofny ERM, Abdel-Motaleb AA, Ghazally A; et al (2019-6). “Platelet-rich plasma is a useful therapeutic option in melasma”. The Journal of dermatological treatment30 (4): 396–401. doi:10.1080/09546634.2018.1524821. PMID30220226.
Sehgal VN, Verma P, Srivastava G et al (2011-12). “Melasma: treatment strategy”. Journal of cosmetic and laser therapy13 (6): 265–279. doi:10.3109/14764172.2011.630088. PMID21981383.
Qianyun Chai, Yutong Fei, Huijuan Cao, Congcong Wang, Jinzhou Tian, Jianping Liu (2015-8). “Acupuncture for melasma in women: a systematic review of randomised controlled trials”. Acupuncture in medicine : journal of the British Medical Acupuncture Society33 (4): 254–261. doi:10.1136/acupmed-2014-010633. PMID25900923.
Huh CH, Seo KI, Park JY et al (2003). “A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma”. Dermatology (Basel, Switzerland)206 (4): 316–320. doi:10.1159/000069943. PMID12771472.
Hofny ERM, Abdel-Motaleb AA, Ghazally A; et al (2019-6). “Platelet-rich plasma is a useful therapeutic option in melasma”. The Journal of dermatological treatment30 (4): 396–401. doi:10.1080/09546634.2018.1524821. PMID30220226.